Tech/AI EU signs a deal with Gilead to provide COVID-19 medicine remdesivir Amwal Al Ghad English Jul 29, 2020 0 The European Union’s executive said it has signed a contract with Gilead for its COVID-19 medicine remdesivir that…
Tech/AI Gilead says to start testing remdesivir in children Amwal Al Ghad English Jun 18, 2020 0 Gilead Sciences Inc, which makes the antiviral drug remdesivir and is now testing it for potential coronavirus…
Tech/AI AstraZeneca is approaching Gilead about a potential merger – the healthcare deal on record Amwal Al Ghad English Jun 8, 2020 0 UK drugmaker AstraZeneca has approached Gilead about a potential merger, a healthcare deal that is expected to be…
News Iran-linked hackers recently targeted coronavirus drugmaker Gilead Amwal Al Ghad English May 9, 2020 0 Hackers linked to Iran have targeted staff at U.S. drugmaker Gilead Sciences Inc in recent weeks, as the company…
Tech/AI New data on Gilead’s remdesivir – released by accident – shows it flops in first… Amwal Al Ghad English Apr 24, 2020 0 Remdesivir developed by Gilead Sciences, a potential antiviral drug to treat coronavirus, has failed in its first…
unclassified Gilead drug shows ‘rapid’ recovery in coronavirus cases, yet it is too early to celebrate Amwal Al Ghad English Apr 18, 2020 0 University of Chicago Medicine researchers said they saw “rapid recoveries” in 125 patients with coronavirus taking…
Tech/AI Investors must be cautious with Gilead’s potential coronavirus drug Remdesivir, analysts… Yomna Yasser Apr 18, 2020 0 As a new report by STAT News showed Gilead’s experimental drug Remdesivir as a promising update on the drug’s…
Egypt News 15 million Egyptians suffer from Hepatitis C: Health Minister Yomna Yasser May 4, 2015 0 Some 15 million Egyptians suffer from Hepatitis C- 22 percent of the population- Health Minister Adel Adawy…
USA S&P 500, Dow End at Record Highs, Boosted by Healthcare Yomna Yasser Nov 19, 2014 0 The Dow and S&P 500 closed at record highs on Tuesday, lifted by further gains in healthcare shares and hopes…